David Hoey

David Hoey, President and CEO of Vaxxas, dives into the future of needle-free vaccine technology, showcasing its potential to enhance immune responses. He discusses the journey from animal trials to human testing and addresses the innovative delivery methods that could transform traditional immunization. The conversation also highlights Brisbane's burgeoning biotech ecosystem and the critical role of mentorship in supporting healthcare innovations. Get ready for a glimpse into the exciting advancements that could reshape vaccine administration!